Partners: Teaming up for Breakthroughs

Scientific Areas of Focus

Select an area below to see where we are focusing our partnering efforts.

• Therapeutic Areas

  • Internal Medicine
  • Inflammation and Immunology
  • Oncology
  • Rare Diseases
  • Vaccines

  • Hospital

• Therapeutic Modalities and Technology Platforms

  • Diagnostics
  • Drug Safety
  • Gene Therapy
  • Medicinal Sciences
    • Biologics Product & Process Development
    • Biotherapeutics Development
    • Medicine Design
    • Small Molecule Product & Process Development
  • Precision Medicine
  • RNA
  • Target Sciences

• Emerging Sciences

  • DNA Damage Response
  • Repeat Expansion
  • Senescence

Partnering Models

What are you looking for in a partnership? Pfizer engages in flexible partnership models that includes research collaborations, venture capital investments, academic alliances for drug development, early stage seed funding, establishing incubators, licensing, and spinning out of companies.

Start a conversation with us. Let's learn about each other and discover synergies, goals, needs and capabilities. There are patients who are waiting, and together, we might deliver on the promise of better health and longer lives.

Academic & Public Partnerships

We engage with academia and other public bodies in a range of partnerships, some models include:

• Centers for Therapeutic Innovation (CTI)

Biotechnology Partnerships

Our biotech partnerships allow us to help you bring your drug or platform to market, with a focus on:

• Licensing options
• Acquisition

Contacts:

• Robert Bagdorf, Candidate through Commercialization

• Uwe Schoenbeck, Discovery through Pre-Candidate

Venture Investments

Our equity investments are active partnerships that seek to identify, support and grow good science from an early stage.

• Pfizer Ventures